Search Results - Pan-Zhou, X R

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells

    Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells by Pan-Zhou, X R, Cui, L, Zhou, X J, Sommadossi, J P, Darley-Usmar, V M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P1244 FAVORABLE PRECLINICAL PROFILE OF IDX21437, A NOVEL URIDINE NUCLEOTIDE PRODRUG, FOR USE IN A DIRECT-ACTING ANTIVIRAL (DAA) REGIMEN FOR HCV

    P1244 FAVORABLE PRECLINICAL PROFILE OF IDX21437, A NOVEL URIDINE NUCLEOTIDE PRODRUG, FOR USE IN A DIRECT-ACTING ANTIVIRAL (DAA) REGIMEN FOR HCV by Gupta, K, Seifer, M, Serra, I, Rashidzadeh, H, Luo, S, La Colla, M, Pan-Zhou, X.-R, Chapron, C, Hernandez-Santiago, B, Mayes, B, Bhadresa, S, Moussa, A, Rush, R

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR

    750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR by Good, S.S, Pan-Zhou, X.-R, Larsson, M, Luo, S, Selden, J.R, Rashidzadeh, H, Bhadresa, S, Camire, M, Parsy, C, Surleraux, D

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    323 PRECLINICAL PHARMACOKINETIC AND SAFETY PROFILE OF IDX375, A NOVEL AND POTENT NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR

    323 PRECLINICAL PHARMACOKINETIC AND SAFETY PROFILE OF IDX375, A NOVEL AND POTENT NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR by Good, S.S, Bu, C, Camire, M, Hernandez-Santiago, B, Larsson, M, Rashidzadeh, H, Pan-Zhou, X.-R, Luo, S, Selden, J, Dousson, C.B, Surleraux, D

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes

    Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes by Pan-Zhou, X R, Cretton-Scott, E, Zhou, X J, Xie, M Y, Rahmani, R, Schinazi, R F, Duchin, K, Sommadossi, J P

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine

    Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine by Pan-Zhou, Xin-Ru, Cretton-Scott, Erika, Zhou, Xiao-Jian, Yang, Ming-Xue, Lasker, Jerome M., Sommadossi, Jean-Pierre

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Involvement of human liver cytochrome P450 3A in vinblastine metabolism : drug interactions

    Involvement of human liver cytochrome P450 3A in vinblastine metabolism : drug interactions by XIN-RU ZHOU-PAN, SEREE, E, XIAO-JIAN ZHOU, PLACIDI, M, MAUREL, P, BARRA, Y, RAHMANI, R

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Phase I Dose-Escalation Pharmacokinetics of AZT-P-ddI (IVX-E-59) in Patients with Human Immunodeficiency Virus

    Phase I Dose-Escalation Pharmacokinetics of AZT-P-ddI (IVX-E-59) in Patients with Human Immunodeficiency Virus by Zhou, Xiao-Jian, Squires, Kathleen, Pan-Zhou, Xin-Ru, Bernhard, Steve, Agrofoglio, Luigi, Kirk, Marion, Duchin, Kenneth L., Sommadossi, Jean-Pierre

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee

    NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee by Standring, D.N., Lanford, R., Wright, T., Chung, R.T., Bichko, V., Cretton-Scott, E., Pan-Zhou, X., Bergelson, S., Qu, L., Tausek, M., Bridges, E., Moussa, A., Storer, R., Pierra, C., Benzaria, S., Gosselin, G., La Colla, P., Sommadossi, J.P.

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: